How FDA Drug Shortage Records Work
The FDA maintains a public record of drug shortages as administrative supply-status entries. This guide explains how those records work, what fields they contain, and how to read and verify a shortage entry as a supply signal rather than a clinical statement.
How FDA drug shortage records work
The FDA maintains a public record of drug shortages. Each entry is an administrative supply-status record: it names the affected product, the reporting company where available, a status describing where the shortage sits in the agency's tracking lifecycle, and supporting fields such as presentation and availability text. This site indexes that data and links each entry back to the official FDA shortage listing.
A shortage record is a supply signal maintained for transparency. It describes a reported supply condition in administrative terms. It does not describe the clinical role of any product, does not suggest any substitute, and does not indicate that any specific patient is affected — those are outside the scope of a regulatory supply record.
How to read an FDA shortage record
A shortage record reproduces the fields published in the FDA drug shortage data: the generic and brand names where available, the reporting company, the status, the presentation, and the availability text supplied by the source. These are administrative supply-status fields describing a reported condition.
To read the record, treat each field as a regulatory data point and confirm the live values at the official FDA shortage listing. The record is a finding aid and a snapshot at ingestion time; it does not describe clinical use and is not a recommendation of any kind.
What "Current" means in the shortage database
In the FDA drug shortage data, a status of "Current" indicates that the shortage is recorded as active in the agency's tracking at the time reflected in the source. It is an administrative status describing the supply record, captured at ingestion time by this site.
Because shortage statuses are updated by the agency as conditions change, a "Current" status indexed here should be confirmed against the live FDA shortage listing before being used for any time-sensitive purpose. The status is a description of a reported supply situation, not guidance about obtaining or using any product.
Resolved vs. discontinued shortage status
Shortage records carry lifecycle statuses. "Resolved" indicates the agency has recorded the supply situation as no longer in shortage, while "Discontinued" indicates the product is recorded as discontinued in the relevant data. Both are administrative descriptions of the supply record's state, not clinical statements.
Distinguishing these statuses matters when interpreting the history of a product's supply in the public data. As with every field on this site, the dependable value is the live one at the official FDA source, which should be confirmed before relying on any status shown here.
What this does not mean
This guide and the underlying shortage data are regulatory information only. They do not constitute medical advice and do not tell you whether to start, stop, switch, or avoid any product. They do not provide diagnosis, treatment, or dosage guidance, and they do not assess safety for any individual.
A regulatory record is an administrative fact about an action or a status. It is not a judgement about a company or a product, and it is not a personalised risk statement. For any health decision, consult a qualified healthcare professional, and treat the official FDA source as the authoritative record.
How to verify the official FDA source
Every record on this site links back to the official FDA drug shortage listing. To verify any detail discussed here, open a relevant record, follow its source link, and confirm the fields — identifiers, status, classification, dates — directly against the agency's published data.
Because public data can lag or omit details held only in primary documents, verification at the official source is always the dependable final step. If a value here differs from the live FDA record, the FDA record governs.
Using this information responsibly
Public FDA regulatory data is most useful when it is treated as a finding aid and an administrative reference. The dependable workflow is to locate the relevant record, read the structured fields as data points rather than instructions, and then confirm the details against the official FDA source before relying on them. This keeps interpretation anchored to what the agency has actually published.
It is equally important to respect the boundaries of the data. A recall or shortage record describes a regulatory action or a supply status; it does not describe the clinical role of any product, does not assess risk for any individual, and is not a judgement about any company. For questions that touch health decisions, a qualified healthcare professional is the right source, and for the authoritative regulatory record, the FDA itself remains the system of record.
Related FDA records
The explanations in this guide describe fields and statuses you can see on real records. Use the links below to open the relevant hubs and example records on this site, then follow each record's source link to confirm the details at the official FDA source.
Frequently asked questions
- What is a drug shortage record?
- It is an administrative supply-status entry naming the product, reporting company where available, and a status in the agency's tracking lifecycle.
- Does a shortage record suggest a substitute?
- No. It is a supply signal and does not suggest substitutes, assess clinical impact, or constitute medical advice.
- Where does the data come from?
- From the FDA drug shortage data, indexed here with a link back to the official listing.
Official FDA sources
Regulatory information only — not medical advice. This guide explains public FDA regulatory data and processes. It does not provide diagnosis, treatment, or dosage guidance, does not assess the safety of any product for any individual, and does not recommend starting, stopping, or switching any product. For health decisions, consult a qualified healthcare professional; for the authoritative record, consult the FDA directly.